Jennifer Cook
Direktor/Vorstandsmitglied bei DENALI THERAPEUTICS INC.
Vermögen: 973 557 $ am 31.05.2024
Profil
Jennifer E.
Cook is currently serving as an Independent Director at Jazz Pharmaceuticals Plc since 2020.
She is also an Independent Director at Denali Therapeutics, Inc. since 2018.
Additionally, she holds the position of Director at BridgeBio Pharma LLC, Ambys Medicines, Inc., and Gyroscope Therapeutics Ltd.
since 2020.
Furthermore, she is an Independent Non-Executive Director at BridgeBio Pharma, Inc. since 2019.
In her former roles, Ms. Cook served as the Chief Executive Officer & Director at GRAIL LLC from 2018 to 2019.
She was also a Non-Executive Director at Gyroscope Therapeutics Holdings Plc from 2020 to 2022.
Prior to that, she held the position of Senior Vice President-Immunology & Ophthalmology at Genentech, Inc. from 2010 to 2013.
She then became the Senior VP & Global Head-Clinical Operations at Roche Pharmaceuticals, Inc. in 2017.
Additionally, she worked as a Principal at Prizm Pharmaceuticals, Inc.Ms. Cook completed her undergraduate and graduate studies at Stanford University.
She also holds an MBA from the Haas School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.05.2024 | 3 813 ( 0,01% ) | 401 318 $ | 31.05.2024 | |
DENALI THERAPEUTICS INC.
0,01% | 06.06.2024 | 20 038 ( 0,01% ) | 371 905 $ | 31.05.2024 |
BRIDGEBIO PHARMA, INC.
0,00% | 01.04.2024 | 7 152 ( 0,00% ) | 200 328 $ | 31.05.2024 |
GRAIL LLC
 GRAIL LLC Medical SpecialtiesHealth Technology GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. 0,08% | 31.08.2020 | 545 607 ( 0,08% ) | 5 $ | 31.08.2020 |
Aktive Positionen von Jennifer Cook
| Unternehmen | Position | Beginn |
|---|---|---|
| DENALI THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 06.11.2018 |
| BRIDGEBIO PHARMA, INC. | Direktor/Vorstandsmitglied | 12.12.2019 |
| JAZZ PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 01.12.2020 |
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Direktor/Vorstandsmitglied | - |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Direktor/Vorstandsmitglied | 01.12.2020 |
Ambys Medicines, Inc.
 Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | 01.03.2020 |
Ehemalige bekannte Positionen von Jennifer Cook
| Unternehmen | Position | Ende |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Direktor/Vorstandsmitglied | 17.02.2022 |
GRAIL LLC
GRAIL LLC Medical SpecialtiesHealth Technology GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Vorstandsvorsitzender | 06.06.2019 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01.12.2017 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Jennifer Cook
| Stanford University | Graduate Degree |
| Haas School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| DENALI THERAPEUTICS INC. | Health Technology |
| BRIDGEBIO PHARMA, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Prizm Pharmaceuticals, Inc. | Health Technology |
GRAIL LLC
GRAIL LLC Medical SpecialtiesHealth Technology GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Ambys Medicines, Inc.
Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Health Technology |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
